What is the price-to-earnings ratio of Merck KGaA?
The price-earnings ratio of Merck KGaA is currently 63.87.
Merck KGaA P/E 2024
Merck KGaA P/E
63.87
Ticker
MRK.DE
ISIN
DE0006599905
WKN
659990
As of Nov 25, 2024, Merck KGaA's P/E ratio was 63.87, a 152.75% change from the 25.27 P/E ratio recorded in the previous year.
The Merck KGaA P/E history
Merck KGaA Aktienanalyse
What does Merck KGaA do?
Merck is one of the oldest and most well-known companies in the pharmaceutical and chemical industry. It was founded as a pharmacy in Darmstadt in 1668 and has since developed into a global company that is successful worldwide. Merck's business model is based on various business areas, all of which are based on scientific research and innovation. The three main business areas are the Life Science, Healthcare, and Performance Materials divisions, all of which focus on providing products and services for a wide range of industries. Life Science is Merck's largest business area, focusing on providing materials, products, instruments, and services for scientific research and biopharmaceutical production. The company offers a wide range of products that focus on the work of researchers and scientists in molecular biology, cell technology, and genomics. Healthcare is another important business area for Merck, focusing on the manufacture and marketing of innovative drugs and treatments for patients. The company offers products for the treatment of diseases such as cancer, multiple sclerosis, and schizophrenia. Performance Materials is Merck's third business area, specializing in the production of materials and technologies for various industries such as the automotive industry, electronics, and packaging. The company focuses on the development of innovative materials such as liquid crystals and organic photovoltaic materials. Merck is also known for its research and development, and the company invests significant resources in developing new products and technologies. This is also evident in the extensive portfolio of products offered by Merck. The company offers a wide range of products ranging from laboratory and analysis equipment to pharmaceuticals and biopharmaceuticals to specialty chemicals. An example of an important product from Merck is the rheumatoid arthritis drug Remicade, which was developed in collaboration with Johnson & Johnson. Merck is also one of the leading manufacturers of liquid crystals for use in displays and electronic devices. Merck is a company committed to social responsibility and sustainability. The company is involved in many areas, including environmental, social, and governance issues. Merck is committed to developing sustainable products and technologies and is dedicated to promoting education, health, and social justice in the communities where it operates. Overall, Merck is a leading company in the pharmaceutical and chemical industry, known for its innovation, research and development, as well as its social responsibility and sustainability. With currently approximately 58,000 employees and annual sales of 17.4 billion euros, the global company network is represented in 67 countries and demonstrates the quality and capabilities of the company worldwide. Merck KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.Merck KGaA revenue by segment
42 % Life Science
42 % Healthcare
16 % Performance Materials
P/E Details
Deciphering Merck KGaA's P/E Ratio
The Price to Earnings (P/E) Ratio of Merck KGaA is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Merck KGaA's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Merck KGaA is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Merck KGaA’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Merck KGaA stock
How has the price-earnings ratio of Merck KGaA changed compared to last year?
The price-to-earnings ratio of Merck KGaA has increased by 152.75% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Merck KGaA high compared to other companies?
Yes, the price-to-earnings ratio of Merck KGaA is high compared to other companies.
How does an increase in the price-earnings ratio of Merck KGaA affect the company?
An increase in the price-earnings ratio of Merck KGaA would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Merck KGaA affect the company?
A decrease in the price-earnings ratio of Merck KGaA would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Merck KGaA?
Some factors that influence the price-earnings ratio of Merck KGaA are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Merck KGaA pay?
Over the past 12 months, Merck KGaA paid a dividend of 2.2 EUR . This corresponds to a dividend yield of about 1.55 %. For the coming 12 months, Merck KGaA is expected to pay a dividend of 2.42 EUR.
What is the dividend yield of Merck KGaA?
The current dividend yield of Merck KGaA is 1.55 %.
When does Merck KGaA pay dividends?
Merck KGaA pays a quarterly dividend. This is distributed in the months of May, May, June, May.
How secure is the dividend of Merck KGaA?
Merck KGaA paid dividends every year for the past 26 years.
What is the dividend of Merck KGaA?
For the upcoming 12 months, dividends amounting to 2.42 EUR are expected. This corresponds to a dividend yield of 1.7 %.
In which sector is Merck KGaA located?
Merck KGaA is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck KGaA kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck KGaA from 5/2/2024 amounting to 2.2 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
When did Merck KGaA pay the last dividend?
The last dividend was paid out on 5/2/2024.
What was the dividend of Merck KGaA in the year 2023?
In the year 2023, Merck KGaA distributed 1.85 EUR as dividends.
In which currency does Merck KGaA pay out the dividend?
The dividends of Merck KGaA are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck KGaA
Our stock analysis for Merck KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
